MRV Scientific Exchange Meeting 2022 – Recording
2022
The Role of Precision Medicine in the Management of Melanoma
Precision medicine may help improve the diagnosis and management of this aggressive skin cancer.
Microsatellites may be associated with poorer survival outcomes in melanoma
The presence of microsatellites was associated with poorer overall survival in a retrospective cohort of patients with cutaneous melanoma, according to a study.
Biomarker Predicts Resistance to Immunotherapies in Melanoma
Duke Cancer Institute researchers have identified potential biomarkers that predict the likelihood for checkpoint inhibitor drugs to backfire, driving hyper-progression of melanoma cells instead of unleashing the immune system to fight them.